These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6454671

  • 1. Urea treatment and pronase digestion of antitumor protein antibiotics, auromomycin and neocarzinostatin.
    Suzuki H, Ozawa S, Tanaka N.
    J Antibiot (Tokyo); 1980 Dec; 33(12):1545-50. PubMed ID: 6454671
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neocarzinostatin and auromomycin preferentially cleave simian virus 40 DNA and chromosomes at a number of discrete locations.
    Grimwade JE, Cullinan EB, Beerman TA.
    Biochim Biophys Acta; 1988 Jul 13; 950(2):102-12. PubMed ID: 2838085
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The generalization of pre-neocarzinostatin and antagonism of neocarzinostatin-induced DNA scission in vitro.
    Jung G, Lewis RS, Köhnlein W.
    Biochim Biophys Acta; 1980 Jun 27; 608(1):147-53. PubMed ID: 6446322
    [Abstract] [Full Text] [Related]

  • 9. Isolation of a non-protein component and a protein component from neocarzinostatin (NCS) and their biological activities.
    Koide Y, Ishii F, Hasuda K, Koyama Y, Edo K, Kitamine S, Kitame F, Ishida N.
    J Antibiot (Tokyo); 1980 Mar 27; 33(3):342-6. PubMed ID: 6445889
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Biological activities of non-protein chromophores of antitumor protein antibiotics: auromycin and neocarzinostatin.
    Suzuki H, Miura K, Kumada Y, Takeuchi T, Tanaka N.
    Biochem Biophys Res Commun; 1980 May 14; 94(1):255-61. PubMed ID: 6446307
    [No Abstract] [Full Text] [Related]

  • 13. Neocarzinostatin: carboxyl-terminal-43-peptide residue of apo-neocarzinostatin as the binding site of neocarzinostatin-chromophore.
    Edo K, Saito K, Akiyama Y, Mizugaki M, Koide Y, Ishida N.
    Chem Pharm Bull (Tokyo); 1986 Dec 14; 34(12):5180-3. PubMed ID: 2952300
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of auromomycin-resistant hamster cell mutants that display a multidrug resistance phenotype.
    Rauscher FJ, Beerman TA, Baker RM.
    Mol Pharmacol; 1990 Aug 14; 38(2):198-206. PubMed ID: 2143555
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of mammalian deoxyribonucleic acid synthesis by neocarzinostatin: selective effect on replicon initiation in CHO cells and resistant synthesis in ataxia telangiectasia fibroblasts.
    Povirk LF, Goldberg IH.
    Biochemistry; 1982 Nov 09; 21(23):5857-62. PubMed ID: 6217834
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The biochemical effect of auromomycin on bacterial cells.
    Suzuki H, Nishimura T, Tanaka N.
    J Antibiot (Tokyo); 1979 Jul 09; 32(7):706-10. PubMed ID: 94325
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.